Free Essay

Personalized Medicine Diagnostics Market

In: Business and Management

Submitted By rajivshah
Words 3516
Pages 15
Renub Research www.renub.com Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing) Market & Forecast

Published: June, 2013
Copyright © 2013 Renub Research – All Rights Reserved

Personalized Medicine - Market Overview
Personalized Medicine is often defined as “the right treatment for the right person at the right time.” Personalized medicine is becoming the place to be in clinical diagnostics as well and slowly becoming the reality of future in the diagnostics industry By Technology Segment - Personalized Medicine diagnostics market is expected to grow with a double digit CAGR for the period of 2013 to 2018. It is expected that personalized medicine diagnostics market by technology is going to double by 2018 from its current market size in 2012. In this segment, Point of Care Testing and Molecular Diagnostics segments control the #1 and #2 positions in 2012. By Diseases Segment - Personalized Medicine diagnostics market is expected to be more than US$ 30 Billion by 2018. Diabetes management test and Cancer management test are the leading market in this segment. Renub Research report entitled “Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)” report provides a comprehensive analysis of the emerging personalized medicine diagnostic market segments, including their dynamics, size, market share, key investors, clinical trials statement, technological trends, company analysis and a realistic future potential for personalized medicine in clinical testing. The report also entails major drivers and challenges of personalized medicine diagnostic market. This 173 page report contains 94 Figures and 16 Tables studies the Personalized Medicine Diagnostics Market. This report contains 12 chapters   Chapter 1 is Executive Summary Chapter 2 contains worldwide personalized medicine diagnostic market & forecast (2011 – 2018). The market includes technological & disease-wise personalized medicine diagnostics market  Chapter 3 contains worldwide personalized medicine diagnostic market share segment. Segment include Technology, Disease-Wise

© Renub Research

Page 2 of 18



Chapter 4 contains segment-wise technological personalized diagnostic market & forecast (2010 - 2018)



Chapter 5 contains geographical segment-wise personalized diagnostic market & forecast (2011 - 2018)



Chapter 6 contains disease-wise personalized diagnostic market share & forecast (2011 - 2018)



Chapter 7 contains disease-wise personalized diagnostic market & forecast (2011 2018)



Chapter 8 and 9 contains clinical trial statement and key investors in Personalized Diagnostics Medicine Market

 

Chapter 10 and 11 contains growth Drivers & Challenges for Personalized Medicine Chapter 12 contains company analysis of Personalized Medicine

Companies analyzed in this report are:      HistoRx A&G Pharmaceuticals Inc 20/20 GeneSystems Tethys Bioscience Genomas Inc

Data Sources This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts.

© Renub Research

Page 3 of 18

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

© Renub Research

Page 4 of 18

Table of Contents
1. Executive Summary

2.

Worldwide Personalized Medicine Diagnostic Market & Forecast 2.1 2.2 By Technology – Worldwide Personalized Medicine Diagnostic Market & Forecast By Diseases – Worldwide Personalized Medicine Diagnostic Market & Forecast

3.

Worldwide – Personalized Medicine Diagnostic Market Share Segment 3.1 3.2 By Technology – Worldwide Personalized Medicine Diagnostic Market Share & Forecast By Disease – Worldwide Personalized Medicine Diagnostic Market Share & Forecast

4.

By Technology – Personalized Medicine Diagnostic Market & Forecast 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 Worldwide – Pharmacogenetics Market & Forecast Worldwide – Pharmacogenomics Market & Forecast Worldwide – SNP Genotyping Market & Forecast Worldwide – Pharmacoproteomics Market & Forecast Worldwide – Biochips Market & Forecast Worldwide – Point of Care Test Market & Forecast Worldwide – Molecular Diagnostics Market & Forecast Worldwide – Genetic Screening Market & Forecast

5.

By Geographical Segmentation – Personalized Medicine Diagnostic Market & Forecast 5.1 5.2 North America – Personalized Medicine Diagnostic Market & Forecast Western Europe (EU5) – Personalized Medicine Diagnostic Market & Forecast

6.

By Disease – Personalized Medicine Diagnostic Market Share & Forecast 6.1 6.2 6.3 6.4 Worldwide – Cardiovascular Management Test Market Share & Forecast Worldwide – Diabetes Management Test Market Share & Forecast Worldwide – Coagulation Test Market Share & Forecast Worldwide – Cancer Management Test Market Share & Forecast

© Renub Research

Page 5 of 18

6.5

Worldwide – Infectious Diseases Test Market Share & Forecast

7.

By Disease – Personalized Medicine Diagnostic Market & Forecast 7.1 Worldwide – Cardiovascular Management Test Market & Forecast

7.2

Worldwide – Cardiovascular Management Test Market & Forecast (By Segment) Cardiac Marker Immunoassays Market & Forecast Cardiac Risk Markers Market & Forecast Cardiac Markers Molecular Test Market & Forecast

7.2.1 7.2.2 7.2.3

7.3

Worldwide – Diabetes Management Test Market & Forecast

7.4

Worldwide – Diabetes Management Test Market & Forecast (By Segment) Blood Glucose Monitoring Market & Forecast Hemoglobin A1C (HbA1c) Test Market & Forecast

7.4.1 7.4.2

7.5

Worldwide – Coagulation Test Market & Forecast

7.6

Worldwide – Coagulation Test Market & Forecast (By Segment) Routine Coagulation Test Market & Forecast Molecular Coagulation Test Market & Forecast

7.6.1 7.6.2

7.7

Worldwide – Cancer Management Test Market & Forecast

7.8

Worldwide – Cancer Management Test Market & Forecast (By Segment) Pharmacodiagnostic Histology Test Market & Forecast Flow Cytometry Market & Forecast Tumor Markers Market & Forecast Human Papillomavirus (HPV) Test Market & Forecast Molecular Assays Market & Forecast Circulating Tumor Cells Market & Forecast

7.8.1 7.8.2 7.8.3 7.8.4 7.8.5 7.8.6

7.9

Worldwide – Infectious Diseases Test Market & Forecast

7.10

Worldwide – Infectious Diseases Test Market (By Segment)

© Renub Research

Page 6 of 18

7.10.1 7.10.2 7.10.3 7.10.4 7.10.5 7.10.6 7.10.7

Human Immunodeficiency Virus (HIV) CD4 Count Market & Forecast Human Immunodeficiency Virus (HIV) Viral Load Test Market & Forecast Hepatitis C (HCV) Viral Load Test Market & Forecast Hepatitis B (HBV) Viral Load Test Market & Forecast Hospital Acquired Infections (HAI) Molecular Test Market & Forecast Sepsis Immunos Test Market & Forecast Multi Drug Resistant Tuberculosis (MDR-TB) Test Market & Forecast

7.11

Worldwide – Microbiology Identification/ Antibiotic Sensitivity Test (ID/AST) Market &

Forecast 7.12 7.13 7.14 Worldwide – Psychiatric Disorders Test Market & Forecast Worldwide – Transplant Tissue Typing (HLA) Test Market & Forecast Worldwide – Molecular Blood Typing Market & Forecast

8.

Personalized Medicine Clinical Trial Statement 8.1 8.2 Biomarker Research for Personalized Medicine in Blood Cancer Patient Genetic & Environmental Determinants of Immune Phenotype Variance: Establishing a Path

towards Personalized Medicine 8.3 Warfarin Adverse Event Reduction for Adults Receiving Genetic Testing at Therapy Initiation

(WARFARIN) 8.4 8.5 8.6 Genetic Analysis for Personalized Medicine for Morbid Obesity Pharmacogenomics for Antidepressant Guidance & Education I-SPY 2 Trial (Investigation of Serial Studies to Predict your Therapeutic Response with

Imaging & Molecular Analysis) 8.7 8.8 8.9 8.10 Genetic Mechanisms in Human Hypertension RAAS Inhibition Study Open Label Study for the Functional Characterization of Drug Metabolism and Transport Personalized Therapy in Non-Small Cell Lung Cancer A Pilot Study of Personalized Medicine for Pediatric Asthma

9.

Key Investors in Personalized Medicine Market

10. 10.1

Key Drivers (Opportunities) of Growth in Personalized Medicine Diagnostic Market Government Agencies Shaping Personalized Medicine Diagnostic Market

© Renub Research

Page 7 of 18

10.2 10.3

Organizations will Profit Together, Not Alone in the Personalized Medicine The Blockbuster Model of One Drug Fits all is under Pressure

11. 11.1 11.2 11.3

Challenges in Personalized Medicine Diagnostic Market Reimbursement Policy & Regulatory Framework Regulatory Framework Payers Worry That Cost of Personalized Medicine Could Be Unsustainable

12. 12.1

Company Analysis HistoRx Focus/Market Served Outlook/ Strategy for Success Products

12.1.1 12.1.2 12.1.3

12.2

A&G Pharmaceutical, Inc Focus/Market Served Outlook/Strategy for Success Products

12.2.1 12.2.2 12.2.3

12.3

20/20 GeneSystems Focus/Market Served Outlook/Strategy for Success Products

12.3.1 12.3.2 12.3.3

12.4

Tethys Bioscience Focus/Market Served Outlook/Strategy for Success Products

12.4.1 12.4.2 12.4.3

12.5

Genomas, Inc. Focus/Market Served Products

12.5.1 12.5.2

© Renub Research

Page 8 of 18

List of Figures

Figure 2-1: Worldwide – By Technology Personalized Medicine Diagnostic Market (Million US$), 2010 – 2012 Figure 2-2: Worldwide – Forecast for By Technology Personalized Medicine Diagnostic Market (Million US$), 2013 – 2018 Figure 2-3: Worldwide – By Diseases Personalized Medicine Diagnostic Market (Million US$), 2011 – 2012 Figure 2-4: Worldwide – Forecast for By Diseases Personalized Medicine Diagnostic Market (Million US$), 2013 – 2018

Figure 3-1: Worldwide – By Technology Personalized Medicine Diagnostic Market Share (Percent), 2010 – 2012 Figure 3-2: Worldwide – Forecast for By Technology Personalized Medicine Diagnostic Market Share (Percent), 2013 – 2018

Figure 4-1: Worldwide – Pharmacogenetics Market (Million US$), 2010 – 2012 Figure 4-2: Worldwide – Forecast for Pharmacogenetics Market (Million US$), 2013 – 2018 Figure 4-3: Worldwide – Pharmacogenomics Market (Million US$), 2010 – 2012 Figure 4-4: Worldwide – Forecast for Pharmacogenomics Market (Million US$), 2013 – 2018 Figure 4-5: Worldwide – SNP Genotyping Market (Million US$), 2010 – 2012 Figure 4-6: Worldwide – Forecast for SNP Genotyping Market (Million US$), 2013 – 2018 Figure 4-7: Worldwide – Pharmacoproteomics Market (Million US$), 2010 – 2012 Figure 4-8: Worldwide – Forecast for Pharmacoproteomics Market (Million US$), 2013 – 2018 Figure 4-9: Worldwide – Biochips Market (Million US$), 2010 – 2012 Figure 4-10: Worldwide – Forecast for Biochips Market (Million US$), 2013 – 2018 Figure 4-11: Worldwide – Point of Care Testing Market (Million US$), 2009 – 2012 Figure 4-12: Worldwide – Forecast for Point of Care Testing Market (Million US$), 2013 – 2018 Figure 4-13: Worldwide – Molecular Diagnostics Market (Million US$), 2010 – 2012 Figure 4-14: Worldwide – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2018 Figure 4-15: Worldwide – Genetic Screening Market (Million US$), 2010 – 2012 Figure 4-16: Worldwide – Forecast for Genetic Screening Market (Million US$), 2013 – 2018

Figure 5-1: North America – Personalized Medicine Diagnostic Market (Million US$), 2011 – 2012 Figure 5-2: North America – Forecast for Personalized Medicine Diagnostic Market (Million US$), 2013 – 2018 Figure 5-3: Western Europe (EU-5) – Personalized Medicine Diagnostic Market (Million US$), 2011 – 2012

© Renub Research

Page 9 of 18

Figure 5-4: Western Europe (EU-5) – Forecast for Personalized Medicine Diagnostic Market (Million US$), 2013 – 2018

Figure 6-1: Worldwide – Cardiovascular Management Test Market Share (Percent), 2011 – 2012 Figure 6-2: Worldwide – Forecast for Cardiovascular Management Test Market Share (Percent), 2013 – 2018 Figure 6-3: Worldwide – Diabetes Management Test Market Share (Percent), 2011 – 2012 Figure 6-4: Worldwide – Forecast for Diabetes Management Test Market Share (Percent), 2013 – 2018 Figure 6-5: Worldwide – Coagulation Test Market Share (Percent), 2011 – 2012 Figure 6-6: Worldwide – Forecast for Coagulation Test Market Share (Percent), 2013 – 2018 Figure 6-7: Worldwide – Cancer Management Test Market Share (Percent), 2011 – 2012 Figure 6-8: Worldwide – Forecast for Cancer Management Test Market Share (Percent), 2013 – 2018 Figure 6-9: Worldwide – Infectious Diseases Test Market Share (Percent), 2011 – 2012 Figure 6-10: Worldwide – Forecast for Infectious Diseases Test Market Share (Percent), 2013 – 2018

Figure 7-1: Worldwide – Cardiovascular Management Test Market (Million US$), 2011 – 2012 Figure 7-2: Worldwide – Forecast for Cardiovascular Management Test Market (Million US$), 2013 – 2018 Figure 7-3: Worldwide – Cardiac Marker Immunoassays Market (Million US$), 2011 – 2012 Figure 7-4: Worldwide – Forecast for Cardiac Marker Immunoassays Market (Million US$), 2013 – 2018 Figure 7-5: Worldwide – Cardiac Risk Markers Market (Million US$), 2011 – 2012 Figure 7-6: Worldwide – Forecast for Cardiac Risk Markers Market (Million US$), 2013 – 2018 Figure 7-7: Worldwide – Cardiac Markers Molecular Test Market (Million US$), 2011 – 2012 Figure 7-8: Worldwide – Forecast for Cardiac Markers Molecular Test Market (Million US$), 2013 – 2018 Figure 7-9: Worldwide – Diabetes Management Test Market (Million US$), 2011 – 2012 Figure 7-10: Worldwide – Forecast for Diabetes Management Test Market (Million US$), 2013 – 2018 Figure 7-11: Worldwide – Blood Glucose Monitoring Market (Million US$), 2011 – 2012 Figure 7-12: Worldwide – Forecast for Blood Glucose Monitoring Market (Million US$), 2013 – 2018 Figure 7-13: Worldwide – Hemoglobin A1C (HbA1c) Test Market (Million US$), 2011 – 2012 Figure 7-14: Worldwide – Forecast for Hemoglobin A1C (HbA1c) Test Market (Million US$), 2013 – 2018 Figure 7-15: Worldwide – Coagulation Test Market (Million US$), 2011 – 2012 Figure 7-16: Worldwide – Forecast for Coagulation Test Market (Million US$), 2013 – 2018 Figure 7-17: Worldwide – Routine Coagulation Test Market (Million US$), 2011 – 2012 Figure 7-18: Worldwide – Forecast for Routine Coagulation Test Market (Million US$), 2013 – 2018 Figure 7-19: Worldwide – Molecular Coagulation Test Market (Million US$), 2011 – 2012 Figure 7-20: Worldwide – Forecast for Molecular Coagulation Test Market (Million US$), 2013 – 2018 Figure 7-21: Worldwide – Cancer Management Test Market (Million US$), 2011 – 2012

© Renub Research

Page 10 of 18

Figure 7-22: Worldwide – Forecast for Cancer Management Test Market (Million US$), 2013 – 2018 Figure 7-23: Worldwide – Pharmacognostic Histology Test Market (Million US$), 2011 – 2012 Figure 7-24: Worldwide – Forecast for Pharmacognostic Histology Test Market (Million US$), 2013 – 2018 Figure 7-25: Worldwide – Flow Cytometry Market (Million US$), 2011 – 2012 Figure 7-26: Worldwide – Forecast for Flow Cytometry Market (Million US$), 2013 – 2018 Figure 7-27: Worldwide – Tumor Markers Market (Million US$), 2011 – 2012 Figure 7-28: Worldwide – Forecast for Tumor Markers Market (Million US$), 2013 – 2018 Figure 7-29: Worldwide – Human Papillomavirus (HPV) Test Market (Million US$), 2011 – 2012 Figure 7-30: Worldwide – Forecast for Human Papillomavirus (HPV) Test Market (Million US$), 2013 – 2018 Figure 7-31: Worldwide – Molecular Assays Market (Million US$), 2011 – 2012 Figure 7-32: Worldwide – Forecast for Molecular Assays Market (Million US$), 2013 – 2018 Figure 7-33: Worldwide – Circulating Tumor Cells Market (Million US$), 2011 – 2012 Figure 7-34: Worldwide – Forecast for Circulating Tumor Cells Market (Million US$), 2013 – 2018 Figure 7-35: Worldwide – Infectious Diseases Test Market (Million US$), 2011 – 2012 Figure 7-36: Worldwide – Forecast for Infectious Diseases Test Market (Million US$), 2013 – 2018 Figure 7-37: Worldwide – HIV CD4 Count Market (Million US$), 2011 – 2012 Figure 7-38: Worldwide – Forecast for HIV CD4 Count Market (Million US$), 2013 – 2018 Figure 7-39: Worldwide – HIV Viral Load Test Market (Million US$), 2011 – 2012 Figure 7-40: Worldwide – Forecast for HIV Viral Load Test Market (Million US$), 2013 – 2018 Figure 7-41: Worldwide – HCV Viral Load Test Market (Million US$), 2011 – 2012 Figure 7-42: Worldwide – Forecast for HCV Viral Load Test Market (Million US$), 2013 – 2018 Figure 7-43: Worldwide – HBV Viral Load Test Market (Million US$), 2011 – 2012 Figure 7-44: Worldwide – Forecast for HBV Viral Load Test Market (Million US$), 2013 – 2018 Figure 7-45: Worldwide – HAI Molecular Test Market (Million US$), 2011 – 2012 Figure 7-46: Worldwide – Forecast for HAI Molecular Test Market (Million US$), 2013 – 2018 Figure 7-47: Worldwide – Sepsis Immunos Test Market (Million US$), 2011 – 2012 Figure 7-48: Worldwide – Forecast for Sepsis Immunos Test Market (Million US$), 2013 – 2018 Figure 7-49: Worldwide – Multi Drug Resistant Tuberculosis (MDR-TB) Market (Million US$), 2011 – 2012 Figure 7-50: Worldwide – Forecast for Multi Drug Resistant Tuberculosis (MDR-TB) Market (Million US$), 2013 – 2018 Figure 7-51: Worldwide – Microbiology ID/AST Market (Million US$), 2011 – 2012 Figure 7-52: Worldwide – Forecast for Microbiology ID/AST Market (Million US$), 2013 – 2018 Figure 7-53: Worldwide – Psychiatric Disorders Test Market (Million US$), 2011 – 2012 Figure 7-54: Worldwide – Forecast for Psychiatric Disorders Test Market (Million US$), 2013 – 2018 Figure 7-55: Worldwide – Transplant Tissue Typing (HLA) Test Market (Million US$), 2011 – 2012 Figure 7-56: Worldwide – Forecast for Transplant Tissue Typing (HLA) Test Market (Million US$), 2013 – 2018

© Renub Research

Page 11 of 18

Figure 7-57: Worldwide – Molecular Blood Typing Market (Million US$), 2011 – 2012 Figure 7-58: Worldwide – Forecast for Molecular Blood Typing Market (Million US$), 2013 – 2018

© Renub Research

Page 12 of 18

List of Tables

Table 3-1: Worldwide – By Diseases Personalized Medicine Diagnostic Market Share (Percent), 2011 – 2012 Table 3-2: Worldwide – Forecast for By Diseases Personalized Medicine Diagnostic Market Share (Percent), 2013 – 2018

Table 7-1: Selected Human Papillomavirus (HPV) Tests, 2011 Table 7-2: Selected Molecular Personalized Medicine Tests in Cancer, 2011

Table 8-1: Clinical Trial – Biomarker Research for Personalized Medicine in Blood Cancer Patient Table 8-2: Clinical Trial – Genetic & Environmental Determinants of Immune Phenotype Variance: Establishing a Path Towards Personalized Medicine Table 8-3: Clinical Trial – Warfarin Adverse Event Reduction for Adults Receiving Genetic Testing at Therapy Initiation Table 8-4: Clinical Trial – Genetic Analysis for Personalized Medicine for Morbid Obesity Table 8-5: Clinical Trial – Pharmacogenomics for Antidepressant Guidance & Education Table 8-6: Clinical Trial – I-SPY 2 Trial (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging & molecular Analysis) Table 8-7: Clinical Trial – Genetic Mechanisms in Human Hypertension RAAS Inhibition Study Table 8-8: Clinical Trial – Open Label Study for the Functional Characterization of Drug Metabolism and Transport Table 8-9: Clinical Trial – Personalized Therapy in Non-small Cell Lung Cancer Table 8-10: Clinical Trial – A Pilot Study of Personalized Medicine for Pediatric Asthma

Table 9-1: Key Investors in Personalized Medicine, 2011 & 2012

Table 12-1: Partnership & Alliance Models in Personalized Medicine

© Renub Research

Page 13 of 18

Related Reports
Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis Point of Care Testing Market and Forecast to 2016: Global Analysis Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis Western Europe (EU-16) In Vitro Diagnostics Market Report & Forecast (2012 – 2015) Asia Medical Tourism Analysis and Forecast to 2015 Clinical Chemistry Market Report & Forecast (2012 – 2015): Global Analysis Hepatitis C (HCV) Market Forecast & Drugs Pipeline Analysis to 2016 Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast Genetic Testing Market and Forecast - Global Analysis 2010 – 2015 USA Cardiovascular Devices Market Trends and Forecast (2010 – 2015) Global Osteoporosis Market & Drugs Analysis 2010 – 2015 Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 – 2015) Global Molecular Diagnostics Market & Future Forecast 2010 - 2014 Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs Analysis Global Cardiovascular Surgery Devices Market Trends and Future Forecast (2009 – 2014)

© Renub Research

Page 14 of 18

Our Partial List of Clients

Redbus Becton Dickinson Pfizer Intercell Sanofi Pasteur Stanford Burgess Pequot Capital DMI Transgene S.A. ixia communications Toyota Tsusho Amercia Inc. National Health Research Institutes Abbott Diabetes Care Corning Incorporated - Life Sciences L.E.K. Consulting GmbH Syntiron MediVas LLC Credit Suisse Dune Medical QIAGEN Inje University Mapp Biopharmaceutical Institute for Information Industry NorDiag ASA Rep e Inv Medicas SA de Innogenetics © Renub Research

Bain WAKE Technology Services, Inc. PSS World Medical Relypsa C&K components Konkuk University Resonetics Samsung SEKISUI MEDICAL CO. LTD. Plentyoffish Media INC Arthur D Little Gmbh Morgan Stanley Takeda Pharmaceutical Corporation Hokkai School of Commerce Ministry of Manpower Singapore GenOmind, LLC. Goldman Sachs & Co NTT Advanced Technology Tokyo Womens Medical University The Chemo-Sero-Therapeutic Research Trade Council of Iceland Jpmorgan, Ets Trading GE Healthcare IT ixia communications

Page 15 of 18

Order Form
Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780 Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to info@renub.com

Format
Report Title: Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)

Single User (Email from Publisher) US$ 1,400

Hard Copy (Mail Delivery) US$ 1,550

CD – Rom (Mail Delivery) US$ 1,500

Global Site License (Multiple User License) US$ 2,200

For ordering this report: Three easy ways to place your order:
1) Order online by Credit Card (Visa, MasterCard, etc.): http://www.renub.com/report/personalized-medicine-diagnostics-flow-cytometry-sepsisimmunos-routine-coagulation-psychiatric-disorders-tumor-markers-molecular-blood-typingand-other-testing-116 2) Order by Wire Transfer: http://www.renub.com/report/wiretransfer.aspx?id=116&pid=1449 To pay by Wire Transfer, please, fill in your contact details in the form below:

© Renub Research

Page 16 of 18

Bank Details
Account Name: Renub Research A/C No.: 109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code: IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi – 110001 India

Contact Information
First Name: Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message: Last Name:

© Renub Research

Page 17 of 18

3) Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research 1St Floor C-86, Sector -10 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us
Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090 LinkedIn: http://www.linkedin.com/company/renub-research Twitter: http://twitter.com/RenubResearch

© Renub Research

Page 18 of 18…...

Similar Documents

Premium Essay

Simple Diagnostic Medicine – Financial Analysis

...Simple Diagnostic Medicine – Financial Analysis Executive Summary Introduction This report provides an analysis and evaluation of the current and prospective profitability, liquidity and financial stability of Simple Diagnostic Medicine (SDM). The purpose of this analysis is to determine if SDM is a suitable investment opportunity. Methods include horizontal and vertical analyses as well as financial ratios examining SDM’s liquidity, solvency and profitability. Other calculations include rates of return on Shareholder’s Equity and Total Assets and Return on Investment. All calculations can be found in the appendices. This report is divided into three sections: the first section presents the financial analysis of SDM’s 1999 and 2000 fiscal year financial statements. The second section is a detailed examination of the financial statements notes and the third section presents our conclusions. Results of the financial statement analysis demonstrate that the company appears to be able to produce significant revenues and profit and is in a relatively good financial position. However, further analysis of the financial statement notes have identified significant areas of concern that weakens SDM’s financial position and profitability, and ultimately forms the bases of our recommendation not to invest in SDM at this time. 1. Financial Statement Analysis Horizontal and Vertical Analysis (Trend Analysis) A complete horizontal analysis for SDM shows significant......

Words: 2420 - Pages: 10

Premium Essay

Personalized Medicine

...How Modern Genetic Technology May Lead to Personalized Medicine While the practice has actually been around for a while now, modern genetic technology is already trying to make its way into mainstream healthcare. There are specialized treatments being developed for breast cancer called Stratified medicine that takes patients and splits them into four groups to see which one respond to the medicine and the ones that don’t are no longer given the treatment. Another treatment is Gene therapy, this treatment looks to change the genome to stop diseases at its root, this treatment has been changed to longer include aggressive courses of action it is now less aggressive and being used more. There are also vaccines available for certain types of cancer as well as ways to reconstruct tissue. Benefits of Personalized Medicine The rise in the technology available to us for our healthcare needs make sure that more and more diseases are stopped before they even get a chance to take hold. Society as whole are becoming more health convince than ever and it is only natural that we would be looking to personalized medicine as our future. Personalized medicine can let us know how well patients will respond to traditional therapies, and allows their health care to be tailored to meet their needs. Patients will then be able to know out front which conditions they would be at greatest risk of contracting and be able to come up with a course of action. Things like change in diets and......

Words: 562 - Pages: 3

Free Essay

Personalized Medicine

...Running Head: PERSONALIZED MEDICINE PERSONALIZED MEDICINE Margaret Barnes SCl115-Introduction to Biology November 07, 2012 PERSONALIZED MEDICINE Personalized Medicine and Modern Genetics Technology: “Introduction” In today’s world DNA sequences are frequently and constantly improving, modern instruments can analyze DNA by the millions within a twenty-four hour period (Mader, 2010, P.178). Because of technology, these instruments have been made available now and in the future for the use of personalized medicinal products. This paper provides an overview of how modern genetic technology may lead to personalized medicine, and to give examples two or more specific benefits of personalized medicine: a discussion of its drawbacks and limitations of the approach to human medicine. “Modern Genetic Technology and Personalized Medicine” Modern technology is constantly growing in our world, for us to understand how modern genetic technology may lead to personalized medicine and the importance personalized medicine. Personalized medicine is the tailoring of medical treatment for an individual with the unique characteristics for each patient. This approach is a......

Words: 821 - Pages: 4

Free Essay

Personalized Medicine

...PERSONALIZED MEDICINE Introduction to Biology Professor Thomas Green LaKeyla Garrett Explanation of how modern genetic technology may lead to personalized medicine. By using DNA technologies such as stem cell research and cloning manipulate human genes. Patients with common disease genetic abnormalities and even spinal injuries may use genetic technology to create personal medicine that may be able to improve and prolong life. An individual risk for common disease would be determined by a genetic profile created from this technology. To create a medical profile tailored to specific DNA characteristics of each patient doctors may use modern genetic technology. The genetic profile would determine treatment and/or preventative care according the effects of a particular disease or patient’s reaction to a certain medical treatments. Discuss the benefits of personalized medicine. Prevention, diagnosis, and treatment in some cancers can be provided by personalized medicine. The use of personalized medicine will allow doctors to develop a more precise treatment based on each patients modern genetic technology because cancer is such a complex disease and effects each individual differently. Genetic diseases affect an estimated 12 million Americans, yet according to a survey of 1,000 people conducted by the Genetic Disease Foundation (GDF), while two-thirds of those surveyed were willing to and saw the benefits of undergoing genetic testing, close to 80 percent had......

Words: 490 - Pages: 2

Free Essay

Personalized Medicine

...Personalized Medicine Introduction to Biology This paper focuses on the representation of the personalized medicine and how the modern techno-scientific has lead for its evolution. Personalized medicine refers to contemporary techno-scientific advantages in modern medicine, such as vitro fertilization technologies, organ transplantation, stem cell therapy, complex life support technologies, etc. The point here is that these and related developments not only continue to stretch and design life, and to boost life expectancy statistics, especially in advanced countries, but they also pose ethical challenges, disadvantages and support a dichotomous relationship between longevity and quality of life. For example, with hundreds of thousands of test tube babies living in the world, in vitro fertilization (IVF) has become much more common. IVF is usually reserved for instances in which a woman suffers from blocked or damaged fallopian tubes or a man has low sperm count. The typical IVF cycle begins with drug treatment designed to control ovulation. One common method is to take five days of nasally administered gonadotropin-releasing hormone analogue (GnRH) to shut down the ovaries, followed by then days of injections of follicle-stimulation hormone (FSH) designed to spur the production of multiple eggs. Blood tests and ultrasound exams help determine the best time to remove the eggs from follicles in the ovaries, which is done surgically bout 36 hours after an injection of...

Words: 872 - Pages: 4

Free Essay

Personalized Medicine

...Personalized medicine is a medical model that emphasizes and bases its application on understanding and using an individual’s personal information. This information includes details about genes, proteins, environmental surroundings during diagnosis, prevention, and in choosing and administering treatments. “Today, when people refer to “Personalized Medicine,” it is generally in the context of using genomics, the science of looking at all the information in the human genome, to tailor medical care to individuals based on their genetic makeup” (Chisholm, 2008). Three areas of technology are the key to making personalized medicine present in our healthcare system. One area involves new tools to decode the human genome (Personalized Medicine: A Vision for a Positive Effect on Healthcare). By mapping this, new approaches have been taken to understand and treat disease. “Cancer and cardiovascular disease are two areas in which genomics are showing promise for treatment advances, although challenges remain” (Personalized Medicine: How Will It Affect Patients?, 2011). The second key area would be to use large-scale studies that help link genetic variation to disease. We would also need “a healthcare technology information system that supports integration of clinical data” (Personalized Medicine: A Vision for a Positive Effect on Healthcare). This would enable physicians to keep track of patient care, to tailor treatment. Breast cancer has been a medical concern for years, and......

Words: 955 - Pages: 4

Premium Essay

Personalized Medicine and Genetic Technology

...Personalized Medicine And Genetic Technology Introduction to Biology SCI 115 Merec Stances Personalized Medicine and Genetic Technology Genomic Technology or what is more popularly known as Personalize Medicine is the personalization of healthcare, with decisions and practices that are tailored to an individual patient. This involves the process of the use of genetic technology or other gathering of information of an individual patient’s preventative and therapeutic care. After more than a decade the U.S. Department of Energy and the National Institutes of Health received a decade of research which was gathered from the Genome Project, (2003). Under this project the Scientist were to learn the order of 3 billion units of DNA which goes into the making of human genome and also to identify the genes located in all this data. By 2003 there was enough chemical makeup that it was pronounced a success. The information received from the Genome project will forever transform the healthcare industry. Many believe personalized medicine is the future of medicine, just the next step in the world of human genetics. Genome is the whole entirety of an organism. It is encoded either in DNA or for different viruses in RNA. The genome has the genes and the non coding sequences of DNA and RNA. The prospects of examining a person’s whole genome and make individual health risk predictions and treatment is within reach. Researchers at Mount Sinai School of Medicine along with...

Words: 615 - Pages: 3

Free Essay

Personalized Medicine

...Personalized Medicine SCI 115 Abstract Personalized medicine is a healthcare field that deals with the different and unique genomic, genetic, clinical, and environmental information of each person. Personalized medicine is based on making treatment or prevention of disease focus on the individual and the factors that do or will affect that particular individual. Some of the advantages of personalized medicine are the ability to make more informed medical decisions, earlier disease intervention, and reduced probability of negative side effects. Although there is a large upside to personalized medicine and the medical advantages that come along with it implementation, there lyes the challenge. The implementation of personalized medicine is the largest limitation. Whether it is lack of push from the healthcare industry or lack of proven technology to properly diagnose individual patients, personalized medicine is very young and has a long way to go. Personalized medicine or medical treatment that is unique to the individual definitely has it advantages. Some of those advantages are the ability to make more informed medical decisions, earlier disease intervention. Laberge and Burke (2008) describe personalized medicine as health care that is tailored to the individual. They go on to say that (Laberge and Burke 2008) recently the term has been used to refer specifically to genetically-based health care. Some of the drawbacks to personalized medicine according to......

Words: 839 - Pages: 4

Premium Essay

Personalized Medicine

...Personalized Medicine Pharmacy has been a key component of medicine for generations. From witch doctors providing herbal remedies, to the recent use of pharmacogenomics, medicine has always worked differently for different people. However, new advances in technology and understanding of the human body have allowed humans to leap forward and save lives. Genetic testing can improve the use of prescription drugs in many ways. Prescription drugs do not always work, and can sometimes be toxic to the users. This is due to the differences between different people and the fact that everyone has a different genetic makeup. For example, Her2/neu genes code for a protein receptor, the Her2 receptor, which deals with cell growth and differentiation. Some polymorphisms in the Her2/neu genes can change how some women’s breasts grow, leading to possible tumors. Cancer can also cause mutations, making the Her2/neu genes overactive, leading to tumors. Thus, women with breast cancer are routinely checked for Her2/neu over-activity. Physicians prescribe a drug called Herceptin to these Her2/neu positive patients. Herceptin does not work as well with patients that are Her2/neu negative, and in fact can be toxic to these patients (1). Thus, genetic testing allows us to change treatments in a way that could be life saving. However, genetic knowledge can change a person’s life, either through ability to act preventatively or by paralyzing a carrier with the weight of a......

Words: 566 - Pages: 3

Premium Essay

Personalized Medicine

...have been breakthrough and impressive. The benefits of personalize medicine are easily recognized. The major benefits of personalized medicine are early diagnostics and, medication and treatments are personalized to an individual for maximum results. Diagnostics use molecules to measure the levels of genes, mutation, and proteins that can be used in the provision of specified therapy that fits the patient health condition. (Science daily, 2010). Our DNA and genes can determine the likelihood of an individual developing certain diseases and how an individual can react to certain medication and treatments. With personalized medicine, medical professionals can analyze a patients genome and identify risk factors to intervene and begin a treatment plan that will best cure/treat/delay the disease of that particular patient. Personalized medicine can change the way professionals approach diseases and illnesses. It has the ability to alter healthcare to further fit their individual needs. Using the individuals genome, personalized medicine has become a future possibility. Personalized medicine is developing medicine, specifically for the individuals genetic makeup and therefore, the effectiveness of treatments for diseases is more effective for each specific patient. Medicine and treatments can be customized to an individual's medical care, to better treat that individual's specific needs. Personalized medicine will be a huge part of the future of medical field. ......

Words: 577 - Pages: 3

Free Essay

Personalized Medicine

...Personalized Medicine Kenneth Weddle Strayer University Science 115 Professor Meri Stanec May 21, 2012 Personalized Medicine Personalized medicine refers to the medical model that entails the customization of healthcare. Under personalized medicine, all the decisions and practices relating to an individual patient are advanced using genetic or any other vital pieces of information. The emergence of personalized medicine has helped in the reduction of costs, time, and the rate of failure of pharmaceutical clinical trials, has eliminated trial and error inefficiencies in the diagnosis of diseases, and has aided in the prescription of effective drugs and averted those that pose dangerous side effects to patients. This essay explicates the manner in which genetic technology may contribute to personalized medicine, examples of the benefits of personalized medicine, and drawbacks of personalized medicine. Modern genetic technology has played an instrumental role in leading to personalized medicine. It has led to in depth understanding of the impacts of genetics in a given disease. The understanding of the impacts of the disease has helped in the development of personalized medicine, as practitioners are able to identify the correct prescription for different diseases. Modern genetic technology has also led to personalized medicine by helping practitioners understand the significance of genes in the normal......

Words: 680 - Pages: 3

Free Essay

The Concept of Personalized Medicine

...The Concept of Personalized Medicine Yvette Stubberfield Strayer University SCI 115 November 16, 2010 Professor Genevieve P. Freeman Personalized Medicine is a new revolutionary break through for doctors and scientists, seeking to treat patients as individuals, based on the actual biology of the disease and not as a member of a population to their symptoms. The whole concept of this new modernized medicine is to avoid wasting time with traditional medicine and risk patients dying before they got the right medicine. The Concept of Personalized Medicine Personalized Medicine is a new revolutionary break through for doctors and scientists, seeking to treat patients as individuals, based on the actual biology of the disease and not as a member of a population to their symptoms. The whole concept of this new modernized medicine is to avoid wasting time with traditional medicine and risk patients dying before they got the right medicine. Scientists have been working on Pharmacogenetics project which is a study of how an individual inheritance variation in genes affect to the body response to a particular drug. Every human being is different and has a unique sequence of genetic information. Individuals respond to drugs differently based on their genes, proteins and environment factors such as: smoking, occupational exposures, alcohol and drug use, exercise and diseases. This study will help tailor drugs to fit our......

Words: 694 - Pages: 3

Premium Essay

Personalized Medicine

...making it possible for medicinal products to become personalized. In this paper I will be explaining how modern genetic technology may lead to personalized medicine; discussing the benefits of personalized medicine; and discussing the drawbacks and limitations of personalized medicine. Explanation of how modern genetic technology may lead to personalized medicine. In order to understand how modern genetic technology may lead to personalized medicine, we need to first understand what personalized medicine is. Personalized medicine is the ability to determine an individual’s unique molecular characteristics and to use those genetic distinctions to diagnose more finely individual’s disease, select treatments that increase the chances of a successful outcome and reduce possible adverse reactions. Personalized medicine is also the ability to predict an individual’s susceptibility to diseases and thus to try to shape steps that may help to avoid or reduce the extent to which an individual will experience a disease. With that being said, the advancement in technology has made it possible for doctors and geneticists use a person’s DNA to find out what kinds of diseases are in their future; thus making it possible for them to make a stepping stone to prevent them. “The completion of the Human Genome Project in 2003 opened the door for better understanding of genetic components of disease that will shape the future practice of medicine. The Human Genome Project detailed the map of......

Words: 887 - Pages: 4

Free Essay

Personalized Medicine

...Personalized Medicine Na’Tasha Slade SCI 115 Professor Palaniswamy August 5, 2012   Personalized Medicine has great influence on the way we think towards identifying and managing healthcare problems and diseases.   Personalize medicine aids in providing an in depth analysis of hereditary differences within genetically difference of people and also how it may affect the healthcare that they may need. With technology being modified daily the advancements in technology may improve the levels of personalize medicine by, giving details on someone metabolic, genetic, and proteinaceous profile that in the future be used to customize individual medical care. The concept of personalized medicine has broadened to include evaluation of your genetic risk of developing disease and determining how serious it may be as well as detecting diseases at much earlier stages—usually before you have symptoms. A personalized medicine approach will also tell you what medicines will work best for you, depending on many different factors, and reduce or eliminate the trial-and-error process of trying to find the right ones. A personalized medicine approach will better monitor disease and treatments and have a better chance of predicting outcomes of therapies and treatment approaches. Personalized medicine usually involves a combination of genetic testing (to determine propensity for certain diseases); suggestions for lifestyle changes; detection of diseases at the molecular level; and......

Words: 541 - Pages: 3

Free Essay

Personalized Medicine

... Wuanda S Green Introduction to Biology Dr. Russell Barnett Personalized Medicine Personalized medicine is a new field of healthcare that is based on an individual’s unique genetic, genomic, clinical and environmental information. The factors vary from one person to another just like the onset of diseases so the purpose of personalized medicine is to react to the individual’s symptoms in the way, with personalized treatment (Jain, 2007). Personalized medicine primary goal and target is to make a treatment as individualize as the person receiving the treatment. This method involves identifying genetic, genomic, and clinical information that will allow accurate predictions to be made about an individual’s susceptibility to a developing disease, the course of that disease and the response to treatment (Cohen, 2008). Modern genetic technology started with the genome project which leads to the benefits and development of personalized medicine (Cohen, 2008). The human genome is the blueprint for each person's body, influencing how we look, our genetic predispositions for certain medical conditions, how well our bodies fight disease or metabolize food, and which therapies our bodies do and do not respond to (Hart, 2005). The genome consists of an organism's total DNA, including its genes. DNA—the famous "double helix"—is composed of four chemicals, which are repeated many times in different sequences (Jain, 2007). (The names of the chemicals are abbreviated as A, T, C, and G....

Words: 751 - Pages: 4